Antitrust: Commission confirms unannounced inspections in the ethylene purchasing sector

The European Commission can confirm that on 16 May 2017 its officials carried out unannounced inspections at the premises of companies active in ethylene purchasing, in several Member States. The Commission has concerns that the companies concerned may have violated EU antitrust rules that prohibit cartels and restrictive business practices (Article 101 of the Treaty [...]

Antitrust: Commission sends Statement of Objections to Teva on ‘pay for delay’ pharma agreement

The European Commission has informed pharmaceutical company Teva of its preliminary view that an agreement concluded with Cephalon was in breach of EU antitrust rules. Under the agreement, Teva committed not to market a cheaper generic version of Cephalon's drug for sleep disorders, modafinil.   Margrethe Vestager, Commissioner in charge of competition policy, said: "Market entry [...]